LGVNLongeveron Inc.

Nasdaq longeveron.com


$ 1.74 $ -0.07 (-3.87 %)    

Friday, 03-May-2024 10:32:56 EDT
QQQ $ 435.80 $ 3.48 (0.8 %)
DIA $ 386.97 $ 0.23 (0.06 %)
SPY $ 511.72 $ 1.19 (0.23 %)
TLT $ 89.82 $ -0.29 (-0.32 %)
GLD $ 212.80 $ -0.61 (-0.29 %)
$ 1.81
$ 1.74
$ 0.00 x 0
$ 2.60 x 200
$ 1.74 - $ 1.74
$ 1.60 - $ 44.00
1,699,644
na
4.55M
$ 0.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-27-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-14-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-11-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 longeverion-granted-israeli-patent-titled-methods-of-using-human-mesenchymal-stem-cells-to-effect-cellular-and-humoral-immunity

https://t.co/L1bepDtcf3

 hc-wainwright--co-maintains-buy-on-longeveron-adjusts-price-target-to-12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Longeveron (NASDAQ:LGVN) with a Buy, adjusts target to $12 from...

 longeveron-raises-a-total-of-114m-in-gross-proceeds-from-warrant-exercise-offering-and-public-offering

Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developin...

 crude-oil-dips-3-us-bancorp-profit-tops-views

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The D...

 why-travelers-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

 nasdaq-down-over-1-sage-therapeutics-shares-plunge

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow trad...

 longeveron-announces-exercise-of-warrants-for-62m-gross-proceeds

Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developin...

 sp-500-down-over-1-us-retail-sales-increase-07-in-march

U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 crude-oil-down-1-charles-schwab-sales-top-estimates

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow tra...

 whats-going-on-with-longeveron-stock

Multiple company executives disclosed large stock purchases after the close on Friday. Joshua Hare, Chief Scientific Officer, p...

 dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.8...

 director-chief-scientific-officer-joshua-hare-of-longeveron-reported-purchase-on-friday-of-297872-shares-at-average-price-of-124

-SEC Filing

 director-rock-soffer-of-longeveron-reported-purchase-on-friday-of-276596-shares-at-average-price-of-124

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION